Management of hormone‐refractory disease
2004; Wiley; Volume: 94; Issue: s3 Linguagem: Inglês
10.1111/j.1464-410x.2004.05141.x
ISSN1464-410X
Autores Tópico(s)Testicular diseases and treatments
ResumoBJU InternationalVolume 94, Issue s3 p. 16-17 Management of hormone-refractory disease C. Hennequin, Corresponding Author C. Hennequin Department of Oncology and Radiation Oncology, Hôpital Saint-Louis, Paris, FranceC. Hennequin, Department of Oncology and Radiation Oncology, Hôpital Saint-Louis, Paris, France. e-mail: christophe.hennequin@sls.ap-hop-paris.frSearch for more papers by this author C. Hennequin, Corresponding Author C. Hennequin Department of Oncology and Radiation Oncology, Hôpital Saint-Louis, Paris, FranceC. Hennequin, Department of Oncology and Radiation Oncology, Hôpital Saint-Louis, Paris, France. e-mail: christophe.hennequin@sls.ap-hop-paris.frSearch for more papers by this author First published: 02 November 2004 https://doi.org/10.1111/j.1464-410X.2004.05141.xCitations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume94, Issues3December 2004Pages 16-17 RelatedInformation
Referência(s)